Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: INmune Bio Q2 Earnings

INmune Bio (NASDAQ:INMB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune Bio beat estimated earnings by 24.0%, reporting an EPS of $-0.38 versus an estimate of $-0.5.
byBenzinga Insights
August 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

INmune Bio (NASDAQ:INMB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

INmune Bio beat estimated earnings by 24.0%, reporting an EPS of $-0.38 versus an estimate of $-0.5.

Revenue was up $16 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.25 which was followed by a 3.87% increase in the share price the next day.

To track all earnings releases for INmune Bio visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Sony Group

By Benzinga Insights
Today, 6:14 PM
Sony Group (NYSE:SONY) is set to give its latest quarterly earnings report on Friday, 2022-07-29. Here's what investors need to know before the announcement. Analysts estimate that Sony Group will report an earnings per share (EPS) of $1.28.

SONY